［5］Sato T, Orlowski KP, Zborowski M. Experimental study of extracorporeal perfusion for septic shock. ASAIO J, 1993,39:M79 0.
［6］Canaud B, Leray-Moragues H, Garred LJ, et al. Slow isolate d ultrafiltration for the treatment of congestive heart failure. Am J Kidney Dis, 1996,28:S67.
［7］Nicolau DP, feng YJ, WU AHB, et al. Evaluation of myoglobi n clearance during continuous hemofiltration in aswine model of a cute renal failure. Int J Artif Organs, 1996,19:578.
［8］Winterberg B, Ramme K, Tenschert W, et al. Hemofiltration in myoglobinutic acute renal failure. Int j Artif Organs, 1990,13: 113.
［9］Berns JS, Cohen RM, Rudnick MR. Removal of myoglobin by CA VH-D intraumatic rhabdomyolysis. Am J Nephrol, 1991,11:73.
［10］Bellomo R, Daskalakis M, Parkin G, et al. Myoglobin clear ance during acute continuous hemodiafiltration. Intensive Care Med, 1991,17:509.
［11］季大玺，谢红浪，刘芸，等.连续性肾脏替代治疗在重症急性肾功能衰竭救中的应用.肾脏病与透析肾移植杂志，1997，6：415.
［12］Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in pat ients during continuous renal replacement therapy. Clin Pharmacokinet , 1993,24:362.
［13］Bellomo R, Mansfield D, Rumble S, et al. A comparison of conventional dialytic therapy and acute continuous hemodiafiltr ation in the management of acute renal failure in the critically Ⅲ. Ren al Failure, 1993,15:595.
［14］Davenport A, Will FJ, Davison AM. Hyperlactatemia and met anolic axidosis during hemofiltration using lactate buffered fluids. N ehron, 1991,59:461.
［15］Schiffl H, Lang SM, Kinig A, et al. Biocompatible membran es in acute renal failure: prospective case-controlled study. Lancet, 1994,344:570.
［16］Lauer A, Alvis R, Avram M. hemodynamic consequences of continuous arterovenous hemofiltration. Am J kidney Dis, 1998,1 2:110.